Resources - general public
Vaccine safety in Australia 2019 – 2 months schedule point
AusVaxSafety is a national system for monitoring vaccine safety in Australia. This infographic provides a visual representation of the number of parents and carers who responded to an SMS about their child’s health a few days after their 2 month vaccinations.
Vaccine safety in Australia – AusVaxSafety summary report 2019
AusVaxSafety is a national system monitoring vaccine safety in Australia. The report shows how people receiving vaccines, or their parents and carers, responded to the SMS about their health a few days after vaccination at each schedule point in the National Immunisation Program in Australia 2019.
COVID-19 vaccination – Australian COVID-19 Vaccination Policy
The Australian COVID-19 Vaccination Policy was published on 13 November 2020. Since that time, significant developments have occurred and the COVID-19 Vaccination Program has evolved over time. This document has not been updated to reflect these changes.
ATAGI – Preliminary advice on general principles to guide the prioritisation of target populations in a COVID-19 vaccination program in Australia
This advice from the Australian Technical Advisory Group on Immunisation (ATAGI) focuses on identifying priority groups for COVID-19 vaccination in Australia.
Why does my child need a flu shot? – fact sheet
Fact sheet answering commonly asked questions about the flu shot (influenza vaccine) for children.
ATAGI strategic intent
The strategic intent of the Australian Technical Advisory Group on Immunisation (ATAGI) includes their vision, purpose, priorities and principles.
Protocols for National Action to Respond to Adverse Events Following Immunisation
Vaccines are safe and effective, but adverse reactions can occur. These protocols outline what to do in the case of a serious adverse event following immunisation, including roles, responsibilities and timelines for action.
The COVID-19 Vaccines and Treatments for Australia – Science and Industry Technical Advisory Group Terms of reference
The terms of reference sets out the role and purpose of the COVID-19 Vaccines and Treatments for Australia – Science and Industry Technical Advisory Group.
Australia’s COVID-19 Vaccine and Treatment Strategy
Our COVID-19 Vaccine and Treatment Strategy outlines how we are investing in promising vaccines and treatments and how they will be safely, fairly and rapidly delivered to Australians.
Vaccinate to protect your baby against meningococcal B – brochure for Aboriginal and Torres Strait Islander people
This brochure provides information for Aboriginal and Torres Strait Islander parents and carers about getting their child vaccinated against meningococcal B disease.
Free meningococcal B vaccine – poster for Aboriginal and Torres Strait Islander people
This poster provides information for Aboriginal and Torres Strait Islander people about the meningococcal B vaccine for infants, and can be used in health care and community settings.
Adolescent meningococcal ACWY vaccine – brochure for Aboriginal and Torres Strait Islander peoples
This brochure includes information for Aboriginal and Torres Strait Islander peoples about the meningococcal ACWY vaccine, available free for adolescents.
Adolescent ‘booster’ dose of diphtheria-tetanus-pertussis (dTpa) vaccine - brochure
This brochure provides information about the diphtheria-tetanus-pertussis (dTpa) vaccine for adolescents.
National HPV vaccination coverage by dose number for adolescents by age group
Historical reports showing national human papillomavirus (HPV) vaccination coverage by dose number (1, 2 or 3) and age group.
National HPV vaccination coverage by remoteness
Historical reports showing national human papillomavirus (HPV) vaccination coverage by remoteness of the area of residence.
Historical Human Papillomavirus (HPV) immunisation coverage rates
Historical reports showing vaccination coverage with 3 doses of human papillomavirus (HPV) vaccine for adolescents turning 15 years of age by year for each state and territory.
National HPV 3 dose vaccination coverage for all adolescents turning 15 years of age from year of program commencement
Historical reports shows vaccination coverage with 3 doses of human papillomavirus (HPV) vaccine for male and female adolescents turning 15 years of age.
National HPV vaccination coverage by socio-economic status
Historical reports showing national human papillomavirus (HPV) vaccination coverage by the socio-economic status of the area of residence.
National HPV vaccination coverage for the female catch up cohort by year of age
Historical reports showing national human papillomavirus (HPV) vaccination coverage for the the female catch up cohort by dose number (1, 2 or 3) and single age cohort (12-26 years) for the specified year.
Vaccine safety in Australia AusVaxSafety summary report 2018
AusVaxSafety is a national system monitoring vaccine safety in Australia. The report shows how people receiving vaccines, or their parents and carers, responded to the SMS about their health a few days after vaccination at each schedule point in the National Immunisation Program in Australia 2018.
2 months schedule point – Vaccine safety in Australia 2018
AusVaxSafety is a national system for monitoring vaccine safety in Australia. This infographic provides a visual representation of the number of parents and carers who responded to an SMS about their child’s health a few days after their 2 month vaccinations.
4 months schedule point – Vaccine safety in Australia 2018
AusVaxSafety is a national system for monitoring vaccine safety in Australia. This infographic provides a visual representation of the number of parents and carers who responded to an SMS about their child’s health a few days after their 4 month vaccinations.
6 months schedule point – Vaccine safety in Australia 2018
AusVaxSafety is a national system for monitoring vaccine safety in Australia. This infographic provides a visual representation of the number of parents and carers who responded to an SMS about their child’s health a few days after their 6 month vaccinations.
12 months schedule point – Vaccine safety in Australia 2018
AusVaxSafety is a national system for monitoring vaccine safety in Australia. This infographic provides a visual representation of the number of parents and carers who responded to an SMS about their child’s health a few days after their 12 month vaccinations.
18 months schedule point – Vaccine safety in Australia 2018
AusVaxSafety is a national system for monitoring vaccine safety in Australia. This infographic provides a visual representation of the number of parents and carers who responded to an SMS about their child’s health a few days after their 18 month vaccinations.
Date last updated: